A recent study [16] showed that CTLA-4 inhibition on CLL cell lines with an elevated expression of CTLA-4 stimulates the survival of malignant cells, whereas CTLA-4 inhibition in the low CTLA-4 expressing CLL cell lines does not affect apoptosis. This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.